Treatment of type II diabetes with metformin, which lowers insulin secretion [14], reduces gastric cancer incidence [15, 16] Type I diabetics have also increased gastric cancer incidence [17, 18], that reaches 3.3-fold after 15 years of insulin therapy [17]. The gene discussed is INS; the disease is type 2 diabetes mellitus.